readthroughSign in
CompanyNBTXNNBXFNasdaq, OTCParis, I0

Nanobiotix S.A.

Nanobiotix develops JNJ-1900, a hafnium oxide nanoparticle injected into tumors and activated by radiotherapy to trigger tumor cell death and immune response.

6-KNov 12Latest SEC filing
Oct 28Latest story